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ABSTRACT 
 
Although the general assumption is that daily and monthly return data are normally distributed 
(Aparicio & Estrada, 2001), the correct statistical distribution of returns must first be established 
(Linden, 2001), as it constitutes one of the elementary building blocks that will ensure accurate 
financial analyses (Taylor, 1986). The assumption of normality is also critical when constructing 
reference intervals for variables (Royston, 1991). By evaluating the pre-, during and post- 2007-
2009 financial crisis periods, this paper found that non-normality can be present in all data 
frequencies, especially in higher data frequencies. Further evidence also illustrated that the 
deviation from normality escalated over the crisis period and remained higher after the crisis, 
compared to the pre-crisis period. By comparing the traditional Sharpe ratio with adjusted 
versions, based on Gatfaoui’s (2012) methodology, this paper accentuates that the presence of 
non-normality and higher moments can influence the Sharpe ratio’s performance rankings. 
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1. INTRODUCTION 
 
merging markets tend be more exposed to shocks which are induced by events, such as exchange rate 
devaluations, regulatory changes, political and global economic crises (SARB, 2010; Bekaert, Erb, 
Harvey & Viskanta, 1998). Even so, emerging markets are generally associated with high expected 
returns and lower correlation with other markets, making it a desirable option to promote greater portfolio 
diversification (Bekaert, Erb, Harvey & Viskanta, 1998). This emphasise the necessity to identify suitable 
investment options in emerging markets by means of a performance evaluation process. However, critical findings 
suggest that the traditional mean-variance analysis approach will not be suitable, as emerging market returns can 
have significant kurtosis and skewness (Bekaert, Erb, Harvey & Viskanta, 1998). This argument is emphasised by 
Hentati, Kaffel and Prigent (2010), who stated that one the greatest criticisms of the standard mean-variance analysis 
approach is that it ignores the higher moments, and that variance will, therefore, provide a flawed perception of 
actual risk (Harlow, 1991). This implies that traditional performance measures, like the Sharpe ratio, will tend to 
overestimate the real risk inherent in the asset classes under evaluation (Brooks & Kat, 2002). Also, very different 
portfolio allocations will be possible, with the presence of non-normal returns, when comparing the traditional 
mean-variance framework to more advanced performance measures (see for example; Wong, Phoon & Lean, 2008; 
Cvitanić, Lazrak, Martellini & Zapatero, 2003; Lamm, 2003; Popova, Morton & Popova, 2003; Terhaar, Staub & 
Singer, 2003; Fung & Hsieh, 1999). Additionally, the study by Harris and Mazibus (2010) argued that volatility 
modelling can assist investors in improving portfolio allocation and performance. However, due to the presence of 
fat tails within return distributions, several volatility models have been found to be inconsistent in describing the 
empirical features of equity indices or option prices (see for example Chernov, Ghysels, Gallant & Tauchen, 2003; 
Eraker, Johannes & Polson, 2003; Andersen, Benzoni & Lund, 2002; Bates, 2000; Bakshi, Cao & Chen, 1997). 
Other fundamental analyses have also examined the statistical distributions of traditional financial ratios and have 
found that these ratios may provide bias information if not adjusted for the presence of non-normality (see for 
example Nikkinen & Sahloström, 2004; Mcleay & Omar, 2000; Deakin, 1976; Horrigan, 1965). Overall, these 
findings emphasise the importance to refrain from assuming that returns are normally distributed, as it can lead to 
inaccurate results and unsuccessful investment decisions.  
E 
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Furthermore, evidence suggested that the characteristics of emerging market returns tend to change 
drastically with the occurrence of market transformation, where a market moves from a state of segmentation to a 
state of integration (Bekaert & Harvey, 2000; 1997; 1995; Bekaert, Erb, Harvey & Viskanta, 1998). This implies 
that the fundamental source of risk can also change as market transformation occurs (Bekaert & Harvey, 2000; 
1997; 1995), making global economic circumstances a more vital contributor to anticipated risk (volatile returns). 
For example, the 2007-2009 financial crisis made insurable profitable investment decisions more difficult as market 
volatility tends to increase during crisis periods (Karunanayake, Valadkhani & O’brien, 2010; Schwert, 1989). This 
can have significant consequences for investors, where traditional performance measures, like the Sharpe ratio, will 
find it difficult to rank more volatile returns (Lo, 2002).  Market transformation will also affect the skewness and 
kurtosis of the market returns, where greater market integration will imply greater market liquidity (Bekaert, Erb, 
Harvey & Viskanta, 1998), which can lead to flawed performance rankings.  
 
In addition, as information does not always arrive linearly at the market and investors do not always react 
immediately to the arrival of new information, it further accentuates the improbability of returns being normally 
distributed. In both instances, the market returns will tend to exhibit a leptokurtic (fat tailed) distribution (Aparicio 
& Estrada, 2001), implying that traditional performance measures, which is based on the standard deviation and beta 
as a risk measure, will generate bias rankings. This necessitates the importance of correctly characterising a market’s 
return distribution over certain time horizons and over different data frequencies, as this will guide investors to 
consult performance measures or volatility measures that are more applicable to the type of return distribution 
present. The goal of this paper is, therefore, not to determine the type of return distribution present, but to show that 
the distribution of returns can impact the efficacy of a traditional risk-adjusted performance measure.  
 
The objectives are, firstly to determine if the return distribution characteristics of several South African 
investments, which will be considered as proxies for suitable emerging market investment options, have changed 
over the 2007-2009 financial crisis period. This will include the evaluation of the higher moments and the level of 
normality. If non-normality is present it will imply that traditional performance measures, which incorporates the 
standard deviation or beta as a risk component, will provide bias results that can lead to different portfolio 
allocations (see for example Amin & Kat, 2003; Brooks & Kat, 2002). Secondly, this paper will determine how the 
return distribution characteristics differ between different data frequencies over the pre-, during and post-financial 
crisis periods. Finally, to further emphasise these objective this paper will also set out to prove that different risk-
adjusted performance rankings will be possible with the presence of non-normality and higher moments and when 
evaluating different data frequencies. The traditional Sharpe ratio (Sharpe, 1966) will be consulted to generate 
several sets of performance rankings. The first set will be based on the proxies that are predominantly non-normally 
distributed during a specific time period for all three different frequencies, which will be confirmed by five different 
normality tests. This will be compared to a second set of rankings that are based on a normally generated version of 
the same non-normally distributed series, while the mean and standard deviation are held constant. This will allow 
an evaluation to illustrate the impact of higher moments on the traditional Sharpe ratio’s performance rankings. The 
rational of this process is based on the notion that traditional performance measures fail to capture higher moments, 
which limit their ranking abilities (Amin & Kat, 2003; Kat, 2003). Also, the possibility of downside surprise can be 
prevented (Lamm, 2003), which traditional risk denominators fail to capture. In order to further emphasise the effect 
of higher moments, the traditional Sharpe rankings, generated from the non-normal returns, will be compared to 
scaled Sharpe rankings that are based on Gatfaoui’s (2012) methodology, which adjust for the presence of higher 
moments (skewness & kurtosis).  
 
The investment options that will be evaluated as proxies will include the returns of several South African 
equity indices, individual shares from the JSE Top 40 index, several short- and long-term bonds yields (capital 
market), money market rates, and several FOREX market rates. In order to achieve these objectives this paper will 
commence by elaborating on the methodology of normality and the variety of tests available (Section 2). Section 3 
will continue by discussing risk-adjusted performance measures, which will focus on their weaknesses and the 
recommended adjustments for the traditional Sharpe ratio (Section 3). This will be followed by a discussion of the 
data and method in Section 4, where the empirical results will be reported in Section 5. The concluding remarks and 
recommendations will continue in Section 6. 
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2. METHODOLOGY OF NORMALITY  
 
In probability theory, the Gaussian distribution (or normal distribution or Gaussian bell curve) is a 
continuous probability distribution, which illustrates the probability of a number falling between any two real 
numbers and can be formulated as follows (Gauss, 1809; Whittaker & Robinson, 1924): 
 
     
 
    
 
 
      
      (1) 
 
where        ;   denotes the expectation of the distribution or the mean;   denotes the standard deviation; 
and    denotes the variance. From Equation 1 it is apparent that a normal distribution is completely dependable on 
the mean     and variance     . This implies that if     and     then the distribution is considered to be a unit 
normal distribution, where a random variable with this distribution will be called a standard normal deviate (Steyn, 
Smit, Du Toit & Strasheim, 1998). Although, if the normality assumption is violated the interpretations and 
inferences of some statistical procedures can become unreliable and invalid (Razali & Wah, 2011), which further 
stresses the importance of establishing the presence of normality. There are several different numerical tests 
available, which can be categorised under five different assortments, which are based on the Chi-squared     , the 
empirical distribution function (EDF), moments, correlation and on entropy, respectively (Arshad, Rasool & 
Ahmad, 2003; Wong & Sim, 2000). The latter assortment of normality tests mentioned, which includes entropy 
based tests, such as the Vasicek tests (Vasicek, 1976) and the Van Es test (Van Es, 1992) will be excluded from this 
paper due to the limitations of current available statistical software packages. In the first assortment, the Pearson’s 
   test (Pearson, 1900) was one of the first normality tests to be developed, which can be formulated as follows 
(Tarongi & Camps, 2010; Yazici & Yolacan, 2007):   
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where    denotes the observed values; and    denotes the expected values within each of the categories    , all 
summed together. However, a key weakness of the    test entails that the sample size must be large enough to 
ensure reliability and accuracy. Though, several studies have proposed possible solutions for the minimum size 
problem of the expected value (see for example Conover, 1980; Cochran, 1952). There is also no exact rule for the 
minimum size of the expected values      in the  
  test estimation (Overholt, 2013) and the test can lose power due 
to the loss of information caused by grouping (Arshad, Rasool & Ahmad, 2003). Nonetheless, due to the    test’s 
versatility and simplicity it is still being applied by present researchers, although evidence have signified the 
superiority of normality tests which are based on the EDF and on correlation (see for example Razali & Wah, 2011; 
Stephens, 1977; 1974;), which is why the    test will not be applied in this paper.  
 
The second assortment of normality tests under investigation includes the tests based on the EDF. Given   
ordered values of a sample  , the EDF can be illustrated as follows (Tarongi & Camps, 2010): 
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where        denotes the step function that increases by 
 
 
 at the value of each ordered data point;       denotes the 
indicator of the event; and    denotes the  
   element of the sample to be evaluated, where the values must be 
ordered from lowest to highest. One of the first normality tests in this assortment to be developed includes 
Kolmogorov’s normality test (Kolmogorov, 1933). This classic normality test compares the EDF of a sample to the 
cumulative distribution function (CDF) of the null distribution. However, the problem with this classic EDF test are 
that prior knowledge of the null distribution’s parameters are required in order to estimate the normality test, which 
is why this test will be excluded from this paper. Though, with the development of the asymptotic theory and Monte 
Carlo studies the critical values for the composite versions of this test can be calculated (D'Agostino & Stephens, 
1986).  
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Alternative EDF normality tests, which will also form the focus point of this paper, include the 
Kolmogorov-Smirnov      tests (Kolmogorov, 1933; Smirnov, 1939), the Cramér-von Misses’       criterion 
(Mises, 1931; Cramér, 1928), the Anderson-Darling      test (Anderson & Darling, 1952), and the Lilliefors     
test (Lilliefors, 1967). According to Arshad, Rasool and Ahmad (2003), the    test, the    test and the     test 
are the most important EDF tests. The study of Stephens (1981) also proved that the    test is the most powerful 
EDF test, followed by the     test and the    test, respectively. The    test correlates the EDF with the normal 
distribution function, where the mean and variance must be a known parameter (Tarongi & Camps, 2010), and can 
be formulated as follows (Yazici & Yolacan, 2007): 
 
                                                                                                                                                                                          
 
where    measures the upper difference between the EDF and the standard normal cumulative distribution function 
      ; and    measures the lower difference between the EDF and     . The    test will consider the largest 
positive difference and the largest negative distance, in absolute terms, between the EDF and the      as the test 
statistic (Overholt, 2013). Furthermore, the    test has two assumptions regarding the data series under 
investigation. Firstly, the data must be from a random sample, which is a similar assumption to that of the    test. 
Secondly, only continuous data can be applied to the    test, whereas any type of data can be applied to the    test. 
Moreover, the    test must have a fully specified hypothesised distribution to compare it with, where this paper will 
measure it against a standard normal distribution. Nonetheless, evidence suggests that the    test has the ability to 
outperform other modern alternatives (in terms of power) with small samples (Overholt, 2013; Seier, 2002). Though, 
it is argued    test may not be as powerful as tests specifically designed to test for normality (Öztuna, Elhan & 
Tüccar, 2006). Additionally, as the mean and variance is not always known, and in order to avoid the errors that can 
be introduced with the estimating of a wrong variance, the Lilliefors     test (Lilliefors, 1967; Tarongi & Camps, 
2010) can be consulted additionally, with the    test as a reference point. With the   test the mean and variance of 
the normal distribution are obtained from the sample   (Lilliefors, 1967). The   test can be formulated as follows 
(Tarongi & Camps, 2010): 
 
   max               , (5) 
1≤i≤N
 
 
where        denotes the value of the  
   element of the EDF of  ; and       is the value of the  
   element of the 
normal distribution function, with the mean      and variance    
   equal to (Tarongi & Camps, 2010): 
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where   denotes the number of observations; and    the sample mean of    The   confidence values are obtained 
from the CDF of the   test results, when applied to a normal distribution (Lilliefors, 1967). Due to the fact that the 
data are standardised, regardless of the mean and variance, the   test is capable of detecting normality of any, even 
unspecified, normal distribution. However, the   test faces some limitations in terms of the process used to derive 
the critical values table for this test. The test statistics of the   test do not follow any known distribution, which 
implies that simulations, such as Monte Carlo simulations must be used to approximate the unknown distributions 
(Overholt, 2013). Furthermore, the   test tends to be more sensitive near the centre of the distribution compared to 
the tails (Tarongi & Camps, 2010). In order to overcome this shortcoming, the Anderson-Darling test      will also 
be consulted in this paper, which gives more weight to the tails (by including a weight function) compared to the   
test. See also the studies of Thadewald and Buning (2007) and of Balakrishnan, Chimitova, Galanova & 
Vedernikova (2013) who highlight the superiority of the    test over other normality tests. 
 
In addition, the    test is based on the comparison of distribution functions, which implies that the values 
of the sample to be evaluated must be ordered. The study of Anderson and Darling (1952) proposed the weighting 
function               
  
 , which will yield the statistic (Tarongi & Camps, 2010; Thode, 2002): 
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where    
     
  
 ;      denotes the standard normal CDF operator. Furthermore,      must be adjusted for the 
sample size as follows (D'Agostino & Stephens, 1986): 
 
           
    
 
 
    
  
     (9) 
 
The critical values can be consulted from the tables of D'Agostino and Stephens (1986), whereas an 
empirical development of the critical values for the normal case can be consulted in the study of Trujillo-Ortiz, 
Hernandez-Walls, Barba-Rojo and Castro-Perez (2007). Although, one of the problems of the    test is with the 
calculation of         and                , because the value of    can be too close to 0 or 1, which will cause 
the logarithm to tend to infinity, thus making the estimation of the test statistic difficult. This problem will occur 
with heavy-tailed distributions and large sample sizes (Archila, 2010), like for example with the evaluation of hedge 
funds. A further variation of the   test, which will also be consulted in this paper, includes the Cramer-von Mises 
      test (Mises, 1931; Cramér, 1928), which originates from a family of tests that compares the squares of the 
differences between the EDF of a sample and the CDF, by estimating the following statistic (Archila, 2010):  
 
                 
             
  
  
     (10) 
 
where         is a weighting function. If           and           then   is the     statistic for testing 
normality (Thode, 2002): 
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where the confidence values can be obtained from the same methodology as the   test.  
 
Although the above mentioned normality tests are highly favoured, none of these tests use higher moments 
(skewness and kurtosis) to differentiate between distributions. This leads to the discussion of the third assortment of 
normality tests, which include the Jarque-Bera      test (Jarque & Bera, 1987) and the D'Agostino-Pearson test 
(D'Agostino & Pearson, 1973). Though, current statistical packages do not always provide the ability of estimating 
the D'Agostino-Pearson test, which is why this test will not be considered in this paper. In terms of the moments 
used in the estimation of these normality tests, the skewness     is a statistical parameter that is related to the 
asymmetry of the probability density function (PDF) of a random variable. The kurtosis    , on the other hand, is a 
statistical parameter that is related to the shape (flatness/peakedness) of the PDF of a random variable (Tarongi & 
Camps, 2010). The third and fourth moments (skewness and kurtosis) can be formulated as follow, respectively 
(QMS, 2009): 
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      (13) 
 
where    denotes an estimator for the standard deviation that is based on the biased estimation for the variance 
        
     
 
 . A normal (Gaussian) random variable will have a skewness of zero, assuming a zero-mean random 
process  , whereas a normal random variable will have a kurtosis of three, independently of its mean and variance 
(Tarongi & Camps, 2010). Furthermore, a return distribution will exhibit a long right tail with a positive skewness 
and a long left tail with a negative skewness. Also, the distribution will be leptokurtic (peaked) with a kurtosis 
greater than three or will be platykurtic (flat) if the kurtosis is less than three (QMS, 2009). A negative kurtosis 
implies that the distribution can be more flat, have shorter tails, or both (Archila, 2010). Moreover, investments, 
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usually hedge funds, which exhibit returns with a leptokurtic distribution and a negative skewness have the 
probability of carrying a downside surprise (see for example Lamm, 2003). This implies that the variance, standard 
deviation and beta will be unable to provide an actual perception of the risk involved, where these measures will 
only demonstrate how the positive returns will be penalised and not the level of ‘hedge fund risk’ involved (Kat, 
2003; Harding, 2002). This further accentuates the importance of evaluating the higher moments of investment 
returns, as this will determine the applicability of consulting certain performance and risk measures during an 
investment decision. Nonetheless, the skewness and kurtosis coefficient have several disadvantages that must first 
be acknowledge. Firstly, both have an unbounded influence function and both have zero breakdown value, which 
imply that bias estimates could be generated with the presence of outliers. Secondly, both are only defined on 
distributions that have finite moments (Brys, Hubert & Struyf, 2008). 
 
 In addition, the first normality test of the third assortment that will be consulted in this paper includes the 
Jarque-Bera      test, which is an asymptotic test that is based on Ordinary Least Square (OLS) residuals. This 
normality test makes use of the standardised skewness and kurtosis, which can be estimated as follows (Gujarati, 
2006): 
 
   
 
 
    
      
 
    (14) 
 
where   is the sample size;   denotes the skewness; and   denotes kurtosis. The     test follows a    distribution 
with 2 degrees of freedom asymptotically (Gujarati, 2006), which can lead to error measurements when the sample 
size is too small (Poitras, 2006; 1992; Dufour, Farhat, Gardiol & Khalaf, 1998; Urzúa, 1996; Jarque & Bera, 1987). 
Moreover, evidence suggests that normality testing that is dependent on robust residuals may outperform normality 
testing that is dependent on OLS residuals (Önder & Zaman, 2005). Several studies have also suggested the use of 
modified versions of the    test can improve results, like for example the study of Brys, Hubert and Struyf (2008). 
Nonetheless, evidence has been found which illustrated that the    test gives the most powerful results for normal 
distributions (Öztuna, Elhan & Tüccar, 2006). The study of Bradley and Morris (2013) also found that the    test 
and Edgeworth expansion of negentropy (Lin, Saito & Levine, 1999) perform similarly.  
 
Finally, the fourth assortment of normality tests are based on correlation and include the Shapiro-Wilk 
     test (Shapiro & Wilk, 1965) and the D’Agostino test (D’Agostino, 1971), where the latter test will be 
excluded from this paper due to the limitations of current statistical packages. The    test that was proposed by 
Shapiro and Wilk (1965) can be formulated as follows (Farrell & Rogers-Stewart, 2006): 
 
   
      
  
    
       
  
   
    (15) 
 
where   denotes the sample mean; the vector                     , with   being the vector of expected values 
of standardised order statistics under normality, and   denotes the corresponding covariance matrix (Farrell & 
Rogers-Stewart, 2006).  The superiority of the    test will have been confirmed by several studies, where Bradley 
and Morris (2013) found that the    test will outperform the    test, the    test and negentropy-based tests 
(Bradley & Morris, 2013). Negentropy-based tests are usually applied to detect normality in source-separation 
problems that involves Independent Component Analysis (ICA). (See for example, Cover & Thomas, 2006; 
Hyvärinen & Oja, 2000). Further evidence also illustrated that the    test can be more superior for detecting 
departures from normality, especially for symmetric long-tailed distributions (Farrell & Rogers-Stewart, 2006). 
Although, Yap and Sim (2011) found evidence that the    test had better power with symmetric short-tailed 
distributions compared to other normality tests. Also, the    test illustrated similar performance with symmetric 
long-tailed distributions, whereas the    test and the    test were found to be the most powerful normality tests 
with asymmetric distributions (Yap & Sim, 2011).  
 
3. METHODOLOGY OF RISK-ADJUSTED PERFORMANCE MEASURES 
 
The mean-variance approach of Markowitz (Markowitz, 1952) is considered as one of the more traditional 
approaches which can assist investors in compiling an efficient portfolio. According to this approach, different 
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assets are combined which minimise the variance for a given level of return. However, one of the greatest criticisms 
of the mean-variance approach is that it ignores the higher moments (Hentati, Kaffel & Prigent, 2010). It is also 
argued that variance and standard deviation do not provide a consistent perception of actual risk (Harlow, 1991), 
especially if the divergence from normality becomes more apparent when the higher moments (skewness & kurtosis) 
of the return distributions are taken into account (Kat, 2003). This implies that the standard deviation can easily be 
manipulated by seeking returns in “non-normal risks”, like extreme liquidity and credit risk and volatility variation 
risks (Amenc, Martellini & Sfeir, 2004:2). Moreover, variance and standard deviation do not differentiate between 
downside and upside risk, which will penalise positive returns (De Wet, Krige & Smit, 2008; Harding, 2002). This 
emphasises the possibility of very different portfolio allocations, with the presence of non-normality returns, when 
comparing the traditional mean-variance framework to more advanced performance measures (see for example, 
Wong, Phoon & Lean, 2008; Lamm, 2003; Popova, Morton & Popova, 2003; Fung & Hsieh, 1999). 
 
Another popular performance evaluation measure to consider is the traditional Sharpe ratio (Sharpe, 1966; 
see Equation 20 below). Though, several studies recommended modified versions of the traditional Sharpe ratio in 
an attempt to replace the flawed standard deviation as a denominator. For example, the modified Sharpe ratio 
(Gregoriou & Gueyie, 2003); the modified Value at Risk (MVaR) model (Favre & Galeano, 2002); the Conditional 
Drawdown at Risk (CDaR) model; the Conditional Value at Risk (CVaR) model (Krokhmal, Palmquist & Uryasev, 
2002); the Cornish-fisher ratio (Liang & Park, 2007); as well as the Polynomial Goal Programming process (PGP) 
used by Davies, Kat and Lu (2009). However, Value-at-Risk (VaR)-based measures are still flawed by its sensitivity 
to the underlying parameters and that the employed calculation method relies on risk factors being normally 
distributed (Van Dyk, Van Vuuren & Heymans, 2014). 
 
Additionally, the traditional Sharpe ratio also assumes that the returns of the individual security are 
uncorrelated with the mean portfolio returns, which can lead to misleading performance rankings in the process 
(Sharpe, 1994). Although, Lo (2002) suggests that the Sharpe ratio can be adjusted for autocorrelation, where the 
method can be formulated by Equation 17 below.  
 
             
      
  
                                                                                                                                                                   
 
       
 
            
   
   
    (17) 
 
where    denotes the average returns of a security;     denotes the risk-free rate;    denotes the standard deviation of 
a security’s returns;    is the traditional Sharpe ratio on a monthly basis, as estimated in Equation 16;     ; and 
   is the  
   autocorrelation for returns.  
 
Another shortcoming of the traditional Sharpe ratio is that it fails to take any benchmark/threshold of a fund 
into consideration to estimate the excess returns, making the evaluation of some portfolios difficult (Amenc, 
Martellini & Sfeir, 2004). Different rankings are also possible for the same portfolio, as each investor has its own 
risk preference and will choose different risk-free rates as benchmark (required return). For example, the study of 
Copeland, Koller and Murrin (2000), Brigham and Ehrhardt (2005) and Samouilhan (2007) consider the 91-day 
Treasury Bill rate as an appropriate proxy for evaluating portfolio performance. However, other studies, such as 
Moolman and Du Toit (2005) and De Wet (2005) consider the R157 bond yield and the R150 bond yield more 
applicable, respectively. Alternative studies also suggest the use of alternative risk-free rates, such as the 10-year 
government bond yield (Copeland, Koller & Murrin, 2000), whereas Botha (2007) and Favre-Bulle and Pache 
(2003) recommended applying the 3-month JIBAR rate and the 3-month LIBOR rate, respectively. Furthermore, 
despite the popularity of the Sharpe ratio one of the greatest criticism of this ratio is its lack of accounting for the 
effect of asymmetry (skewness) and the heaviness of the distribution tails (kurtosis), which can influence the validity 
of the standard deviation or beta as risk measures. These risk measure are flawed as they are based on return 
variances, which measures only the dispersion of returns around its historical average and penalises positive and 
negative deviations from the historical average in a similar manner, leading thus to a misperception of actual risk 
(Lhabitant, 2004). In order to account for skewness and kurtosis, Gatfaoui (2012) propose that the following 
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adjustments must be made in order to estimate an adjusted (scaled) Sharpe ratio, which can be formulated as follow: 
 
                              
   
   
    
   
   
    (18) 
 
                           
    
      
   
    
      
   
                                                                                                  
 
where         and        , with    and    denoting the number of observations below and above the 
mean of the security,   denotes the total number of observations under investigation;     denotes negative excess 
returns;     denotes positive excess returns;    denotes the average returns of a security (with     and     denoting 
the left-skewed and right-skewed returns, respectively);     denotes the risk-free rate; and    denotes the standard 
deviation of the security’s returns (with     and    denoting the downside and upside deviations, respectively). 
 
4. DATA AND METHOD 
 
Daily, weekly and monthly closing prices will be evaluated (average closing prices were used with the 
weekly & monthly data frequencies), spanning from January 2005 to the end of December 2013. This time span will 
also be used to evaluate if the 2007-2009 financial crisis had an effect on market return distribution characteristics. 
This will be accomplished by dividing this time span into three time periods, namely a pre-financial crisis period, a 
during financial crisis period and a post-financial crisis period. The pre-financial crisis period (period 1) spans from 
January 2005 to December 2006, whereas the during financial crisis period (period 2) spans from January 2007 to 
December 2009 and the post-financial crisis period (period 3) spans from January 2010 to December 2013. The time 
span of period 1 was limited due to the unavailability of capital market rates that are under investigation, which were 
only available from January 2005. Furthermore, the during financial crisis period (period 2) was carefully 
constructed to incorporate key events to ensure that the impact of the crisis can be evaluated effectively. Period 2 
starts by incorporating the date when the Federal Home Loan Mortgage Corporation (Freddie Mac) announced that 
no more risky subprime mortgages and mortgage-related securities will be bought (27 February 2007). It also 
includes the event when Northern Rock was taken into state ownership by the Treasury of the United Kingdom (17 
February 2008); the announcements of Lehman Brothers Holdings Incorporated filing for bankruptcy on 15 
September 2008); and continues until after the announcement when president Obama signed the American Recovery 
and Reinvestment Act of 2009, which included a variety of tax cuts and spending measures that were intended to 
promote economic recovery in the United States.  
 
The 33 South African investment options that will be evaluated include investment proxies from the equity 
market, money market, capital market, FOREX market and other types, like the 1-ounce Kruger Rand, as reported in 
Table 1. All the closing price data were collected from the McGregor BFA (2013) database. The individual shares 
that will be evaluated comprise out of the top 14 shares of the JSE Top 40 index, based on the market capitalisation 
of 11 July 2014.  
 
The empirical study will commence by evaluating the two higher moments (skewness & kurtosis) of each 
of the return series over different data frequencies to determine if distribution characteristics changed over the three 
time periods. The empirical study will then continue by establishing if the return distributions (with different data 
frequencies) exhibited normality/non-normality over the three time periods. This will be determined by consulting 
several normality tests, which are based on the empirical distribution function (EDF), moments and correlation, 
respectively, in order to generate more conclusive results. The normality tests that are based on the EDF will include 
the Kolmogorov-Smirnov      tests with the Lilliefors correction, the Cramér-von Misses’       test and the 
Anderson-Darling      test. The normality tests that will be consulted in this paper which are based on moments 
and correlation will entail the Jarque-Bera      test and the Shapiro-Wilk      test, respectively. These analyses 
will be conducted with the EViews 7 program (QMS, 2009) and the IBM
®
 SPPS Statistics, version 22 program 
(IBM, 2013), respectively. 
 
  
The Journal of Applied Business Research – January/February 2015 Volume 31, Number 1 
Copyright by author(s); CC-BY 205 The Clute Institute 
Table 1: South African Investment Options Under Investigation 
EQUITY MARKET 
MONEY MARKET# 
Indices 
JSE All Share index (J203) 1-month JIBAR yields 
JSE Financial index (J580) 3-month JIBAR yields 
JSE Bank index (J835) 6-month JIBAR yields 
JSE Industrial index (J520) 9-month JIBAR yields 
JSE Top 40 index (J200) 12-month JIBAR yields 
Individual shares from the JSE Top 40 index 
CAPITAL MARKET* 
Name+ Sector 
SABMiller Plc. (SAB) Consumer Staples R157 bond rate 
BHP Billiton Plc. (BIL) Materials R186 bond rate 
Compagnie Financière Richemont (CFR) Consumer discretionary 1-to-3 year bond index 
Naspers Limited (NPN) Communication 3-to-7 years bond index 
MTN Group Limited (MTN) Communication Over 12 year bond index 
Sasol Limited (SOL) Energy 
FOREX MARKET 
Anglo American Plc. (AGL) Materials 
Standard Bank Group Limited (SBK) Financials ZAR/USD exchange rate 
FirstRand Limited (FSR) Financials ZAR/EUR exchange rate 
Old Mutual Plc. (OML) Financials ZAR/GBP exchange rate 
Barclays Africa Group Limited (BGA) Financials 
Other 
Sanlam Limited (SLM) Financials 
Aspen Pharmacare Holdings Limited (APN) Health care 
1-ounce Kruger Rand (KR) 
Anglo American Platinum Limited (AMS) Materials 
Source: Compiled by author. 
+ Note: Due to the unavailability of data for the required periods under investigation this paper was unable to evaluate the prime rate and the 91-
day Treasury Bill rate as additional money market rates; the JSE Resources index; and British American Tobacco Plc., Glencore Plc. and 
Vodacom Group Limited as three of the individual shares of the JSE Top 40 index.  
# Note: The annual yields where converted to daily, weekly and monthly yields, respectively, in order to evaluate the descriptive statistics. This 
ensures that all the data under investigation are in the same format. 
*Note: The annual yields to maturity of the bonds were converted to daily, weekly and monthly annualised yields before the empirical study 
commenced. 
 
Finally, the performance ranking evaluation will continue with the proxies that are predominantly non-
normally distributed during a specific time period for all three different frequencies. This ranking evaluation will 
commence by generating normally distributed versions of these series by applying Equation 1 (see Section 2) and by 
keeping the mean and standard deviation constant. This will be followed by applying the traditional Sharpe ratio to 
both of the non-normal and normally distributed series, where the findings will illustrate how the presence of non-
normality and higher moments can influence performance rankings. These rankings will then be compared to scaled 
Sharpe rankings that are based on the non-normal return series (based on Equation 18 & 19, respectively). 
 
5. RESULTS 
 
The first step of the empirical study is to evaluate the skewness and kurtosis of the different frequencies, as 
they can influence the creditability of the traditional Sharpe ratio. The results reported in Table 2 illustrate that there 
is a linear relationship between the average kurtosis and the frequency level. Daily data always exhibit a higher 
average kurtosis during all three time periods, including the entire sample period, compared to weekly and monthly 
frequencies. Also, Table 2 reports that the different series under investigation are on average leptokurtic (kurtosis 
greater than three), which emphasise the results found by Heymans and Van Heerden (2014). Furthermore, the 
results from Table 2 report a linear relationship between the skewness and the frequency level, which implies that 
daily data will exhibit a higher average skewness compared to weekly and monthly data. However, this linear 
relationship is absent during the financial crisis period, where monthly data illustrate a higher average skewness 
compared to weekly data.  
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Table 2: Summary Of Four Moments (Averages Of 33 Investment Proxies) 
Sample Average Skewness Average Kurtosis 
Entire sample (Daily frequency) 1.690 89.439 
Entire sample (Weekly frequency) 0.068 8.128 
Entire sample (Monthly frequency) -0.090 4.602 
Pre-financial crisis period (Daily frequency) 0.934 19.884 
Pre-financial crisis period (Weekly frequency) 0.293 3.528 
Pre-financial crisis period (Monthly frequency) 0.257 3.048 
During financial crisis period (Daily frequency) 0.256 16.118 
During financial crisis period (Weekly frequency) -0.010 5.942 
During financial crisis period (Monthly frequency) -0.077 3.597 
Post-financial crisis period (Daily frequency) 0.181 4.886 
Post-financial crisis period (Weekly frequency) 0.168 3.904 
Post-financial crisis period (Monthly frequency) 0.025 3.862 
Source: Compiled by author. 
Note: See Table A in the Appendix for the complete results. 
 
Finally, it is interesting to note that higher frequency data tend to exhibit a more dominant presence of 
higher moments when evaluating the investment proxies individually (see Table A in the Appendix). Besides daily 
data, which tend to exhibit higher moments throughout the different frequencies and periods under investigation, the 
presence of higher moments is the greatest during the financial crisis period for both the weekly and monthly 
frequencies. Furthermore, the presence of higher moments is also more dominant during the post-financial crisis 
period compared to pre-financial crisis period (see Table A in the Appendix). These findings imply that financial 
analysts should still be cautious when consulting traditional risk-adjusted performance measures, as the higher 
moments will corrode the accuracy of the performance rankings. The effect of the higher moments is further 
emphasised by the results found by the Jarque-Bera test, which illustrates that the presence of non-normality is 
greater with daily data compared to weekly and monthly data (See Table A in the Appendix). The presence of non-
normality is further highlighted by four additional normality tests, which concur that the assumption that daily and 
monthly return data are normality distributed is flawed. All the different frequencies exhibit a certain presence of 
non-normality, with monthly data exhibiting the lowest presence of non-normality and daily data the highest. Also, 
all three frequencies exhibit the same trend, where the presence of non-normality increased during the crisis period 
and remained higher during the post-financial crisis compared to the pre-financial crisis period (See Table 3 & Table 
A in the Appendix).  
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Table 3: Summary Of Normality Tests 
  
DAILY FREQUENCY  WEEKLY FREQUENCY  MONTHLY FREQUENCY  
Entire 
Sample 
Pre-
Crisis 
Period 
During 
Crisis 
Period 
Post-
Crisis 
Period 
Entire 
Sample 
Pre-
Crisis 
Period 
During 
Crisis 
Period 
Post-
Crisis 
Period 
Entire 
Sample 
Pre-
Crisis 
Period 
During 
Crisis 
Period 
Post-
Crisis 
Period 
1-month 
JIBAR 
No No No No No No No No No No No No 
3-month 
JIBAR 
No No No No No No No No No No No No 
6-month 
JIBAR 
No No No No No No No No No No No No 
9-month 
JIBAR 
No No No No No No No No No No No No 
12-month 
JIBAR 
No No No No No No No No No No No No 
R 157 No No No No No No No No No Yes No No 
R 186 No No No No No No No No Yes Yes Yes No 
1-to-3 year 
bond index 
No No No No No No No No No Yes No No 
3-to-7 year 
bond index 
No No No No No No No No No Yes No No 
12+ month 
bond index 
No No No No No Yes No No No Yes No No 
JSE All 
Share 
No No No No No No No No No No No No 
JSE Top 40 No No No No No No No No No Yes No No 
JSE Bank No No No No No No No Yes No Yes Yes Yes 
JSE 
Financials 
No No No No No Yes No Yes No Yes Yes Yes 
JSE 
Industrials 
No No No No No No No Yes No Yes No No 
AGL No No No No No No No Yes No Yes Yes Yes 
BIL No No No No No Yes No Yes Yes Yes Yes Yes 
CFR No No No No No Yes No Yes No No No No 
FSR No No No No No Yes No No No Yes No No 
MTN No No No No No Yes No No Yes Yes Yes Yes 
NPN No No No No Yes Yes Yes Yes Yes Yes Yes Yes 
OML No No No No No No No No No Yes Yes Yes 
SAB No No No No No No Yes Yes No Yes Yes Yes 
SBK No No No No No Yes No Yes Yes Yes Yes Yes 
SOL No No No No No Yes No Yes No Yes No No 
BGA No No No No No Yes Yes No Yes Yes Yes Yes 
SLM No No No No No Yes Yes No Yes Yes Yes Yes 
APN No No No No No No No No No Yes Yes Yes 
AMS No No No No No No No Yes No No No No 
ZAR/EUR No No No No No No No No No No No Yes 
ZAR/GBP No No No No No Yes No No No No No Yes 
ZAR/USD No No No No No Yes No No No Yes No Yes 
Kruger 
Rand 
No No No No No No No No No No No No 
Source: Compiled by author. 
Note: “Yes” implies that none of the five normality tests rejected the null hypothesis; “No” implies that at least one of the five normality tests 
rejected the null hypothesis. 
Note: See Table A in the Appendix for the complete results. 
 
Overall, from these results it is conclusive that higher moments and non-normality are present in all three 
different data frequencies and during all three time periods under investigation, including the entire sample period. 
There is also evidence which suggests that the characteristics of the different return distributions exhibited 
significant change during the financial crisis period, especially for the weekly and monthly data series, and poses a 
challenge for risk-adjusted performance evaluations even after the crisis period. This implies that the reliability of 
the traditional Sharpe ratio is doubtful, which can lead to misleading investment decisions. To confirm this 
argument, all the investment proxies with non-normal return distributions and high moments during the financial 
crisis period will be evaluated. The financial crisis period was chosen as it provides the most suitable settings to 
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conduct this risk-adjusted performance evaluation, as the presence of higher moments and non-normality was found 
to be the greatest during this period. The investment proxies chosen entail the JSE All Share index, the JSE Top 40 
index, Compagnie Financière Richemont (CFR), Sasol Limited (SOL), the ZAR/EUR exchange rate, the ZAR/GBP 
exchange rate, the ZAR/USD exchange rate, the 1-ounce Kruger Rand (KR). Finally, the R157 bond rate was chosen 
as the risk-free rate proxy, which is based on the study of Moolman and Du Toit (2005). To illustrate how the 
presence of non-normality and higher moments can lead to different Sharpe rankings, compatible normality 
distributed return series must be generated for each of the nine non-normally distributed investment proxies under 
investigation. By keeping the mean and standard deviation constant, a normally distributed series were generated for 
each of the proxies in the three different data frequencies (by applying Equation 1 from Section 2), which also do 
not suffer from higher moments, as reported in Table 4. The adequacy of these normally distributed series is 
confirmed by the five different normality tests, which is not reported in this paper. 
 
Table 4: Descriptive Summary Of The Normal And Non-Normal Series Under Investigation 
  
DAILY FREQUENCY WEEKLY FREQUENCY 
ORIGINAL NON-NORMAL SERIES 
NORMAL 
SERIES 
ORIGINAL  
NON-NORMAL SERIES 
NORMAL 
SERIES 
Mean Std. Dev. Skew. Kurt. Skew. Kurt. Mean Std. Dev. Skew. Kurt. Skew. Kurt. 
R157 0.023% 0.002% 0.993 4.148 -0.054 2.964 0.163% 0.013% 0.960 4.099 -0.211 2.816 
JSE All Share 0.029% 1.740% 0.024 4.947 0.006 2.718 0.109% 2.972% -0.015 3.898 0.182 2.910 
JSE Top40 0.031% 1.897% 0.080 4.946 -0.025 2.913 0.114% 3.204% 0.056 4.144 -0.124 2.831 
CFR -0.030% 2.565% -4.277 65.321 0.021 2.905 -0.194% 4.601% -2.153 12.885 0.121 2.769 
SOL 0.058% 2.803% 0.329 5.169 -0.040 2.842 0.197% 4.618% -0.345 4.666 -0.044 2.627 
ZAR/EUR 0.019% 1.332% 2.187 30.345 0.010 2.997 0.104% 1.934% 0.399 4.925 -0.182 2.481 
ZAR/GBP -0.024% 1.357% 1.773 25.297 0.071 2.981 -0.070% 2.069% 0.226 4.816 0.192 2.502 
ZAR/USD 0.025% 1.505% 2.111 26.625 0.034 2.753 0.060% 2.314% 1.261 6.865 -0.136 2.691 
Kruger Rand 0.103% 2.098% 0.234 7.165 -0.044 2.901 0.407% 2.648% 0.684 5.108 -0.027 2.840 
  
MONTHLY FREQUENCY 
 
ORIGINAL NON-NORMAL SERIES 
NORMAL 
SERIES 
Mean 
Std. 
Dev. 
Skew. Kurt. Skew. Kurt. 
R157 0.705% 0.057% 1.000 3.823 0.128 2.185 
JSE All Share 0.496% 5.576% -1.228 4.695 0.035 2.315 
JSE Top40 0.508% 5.848% -1.179 4.526 0.152 2.318 
CFR -0.725% 10.011% -2.163 9.219 -0.058 2.143 
SOL 0.700% 7.643% -0.816 4.484 0.115 2.641 
ZAR/EUR 0.538% 4.163% 0.843 4.432 0.043 2.515 
ZAR/GBP -0.263% 4.207% 1.230 5.509 0.203 2.949 
ZAR/USD 0.299% 5.181% 1.824 9.498 0.406 2.205 
Kruger Rand 1.856% 6.195% 0.759 4.373 -0.078 2.224 
Source: Compiled by author. 
 
The next step of the empirical study is to provide a risk-adjusted performance comparison between the 
rankings generated from normally distributed returns and that of non-normally distributed returns. A traditional 
Sharpe ratio and a serial correlated adjusted (SC) Sharpe ratio were estimated for both of the normally and no-
normally distributed proxies. Additionally, two scaled Sharpe ratio versions, based on the study of Gatfaoui (2012), 
were estimated on the non-normal proxies to further emphasise the effects of higher moments. From the results 
reported in Table 5 it is evident that the presence of higher moments and non-normality will have a significant 
influence on the rankings provided by the Sharpe ratio. There seems to be no linear relationship present between the 
Sharpe rankings that are based on the normally distributed and non-normally distributed returns, respectively. This is 
true for all three data frequencies, although, the only exception is with the non-normally daily data, where the 
rankings between the traditional Sharpe ratio, the serial correlated adjusted (SC) Sharpe ratio and the SC scaled 
Sharpe ratio (S**) did not differ.  
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Table 5: Ranking Summary Of Different Sharpe Versions (During The Financial Crisis Period) 
NON-NORMAL SERIES (DAILY FREQUENCY) 
Traditional Sharpe SC Adjusted Sharpe Scaled Sharpe (S*) 
SC Scaled  
Sharpe (S*) 
Scaled Sharpe (S**) 
Sc Scaled  
Sharpe (S**) 
Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate 
Kruger 
Rand 
0.470 Kruger Rand 0.739 CFR 0.070 CFR 0.151 Kruger Rand 0.684 
Kruger 
Rand 
1.074 
SOL -0.025 SOL -0.065 ZAR/GBP 0.052 ZAR/GBP 0.107 SOL -0.039 SOL -0.101 
JSE Top 40 -0.081 JSE Top 40 -0.138 
Kruger 
Rand 
-0.032 Kruger Rand -0.048 JSE Top 40 -0.122 
JSE Top 
40 
-0.207 
JSE All 
Share 
-0.084 JSE All Share -0.141 ZAR/EUR -0.062 SOL -0.141 
JSE All 
Share 
-0.124 
JSE All 
Share 
-0.209 
ZAR/USD -0.100 ZAR/USD -0.256 SOL -0.065 JSE Top 40 -0.150 ZAR/USD -0.172 ZAR/USD -0.439 
ZAR/EUR -0.153 ZAR/EUR -0.398 JSE Top 40 -0.068 
JSE All 
Share 
-0.151 ZAR/EUR -0.247 ZAR/EUR -0.642 
CFR -0.495 CFR -1.039 ZAR/USD -0.068 ZAR/EUR -0.159 ZAR/GBP -0.744 CFR -1.867 
ZAR/GBP -0.614 ZAR/GBP -1.781 
JSE All 
Share 
-0.069 ZAR/USD -0.173 CFR -0.890 ZAR/GBP -2.157 
NON-NORMAL SERIES (WEEKLY FREQUENCY) 
Traditional  
Sharpe Ratio 
SC Adjusted  
Sharpe Ratio 
Scaled Sharpe  
Ratio (S*) 
SC Scaled  
Sharpe Ratio (S*) 
Scaled Sharpe  
Ratio (S**) 
SC Scaled Sharpe 
Ratio (S**) 
Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate 
Kruger 
Rand 
1.654 
Kruger 
Rand 
3.326 CFR 0.079 CFR 0.167 Kruger Rand 2.836 
Kruger 
Rand 
5.701 
SOL -0.229 SOL -0.628 ZAR/GBP 0.062 ZAR/GBP 0.122 SOL -0.343 SOL -0.941 
JSE Top 40 -0.437 JSE Top 40 -1.059 
Kruger 
Rand 
-0.067 ZAR/EUR -0.094 JSE Top 40 -0.700 
JSE Top 
40 
-1.698 
JSE All 
Share 
-0.462 
JSE All 
Share 
-1.094 ZAR/EUR -0.071 SOL -0.103 
JSE All 
Share 
-0.726 
JSE All 
Share 
-1.720 
ZAR/EUR -0.574 ZAR/EUR -1.310 SOL -0.078 ZAR/USD -0.144 ZAR/EUR -0.959 ZAR/EUR -2.190 
ZAR/USD -0.757 CFR -1.444 
JSE All 
Share 
-0.086 Kruger Rand -0.146 ZAR/USD -1.581 ZAR/GBP -2.506 
CFR -0.953 ZAR/USD -1.691 JSE Top 40 -0.089 
JSE All 
Share 
-0.159 ZAR/GBP -1.982 CFR -3.274 
ZAR/GBP -1.439 ZAR/GBP -1.819 ZAR/USD -0.090 JSE Top 40 -0.168 CFR -2.160 ZAR/USD -3.532 
NON-NORMAL SERIES (MONTHLY FREQUENCY) 
Traditional  
Sharpe Ratio 
SC Adjusted  
Sharpe Ratio 
Scaled Sharpe  
Ratio (S*) 
SC Scaled  
Sharpe Ratio (S*) 
Scaled Sharpe  
Ratio (S**) 
SC Scaled Sharpe 
Ratio (S**) 
Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate 
Kruger 
Rand 
0.573 
Kruger 
Rand 
1.300 CFR 0.283 ZAR/GBP 0.639 
Kruger 
Rand 
1.086 
Kruger 
Rand 
2.464 
SOL -0.136 SOL -0.199 ZAR/GBP 0.149 CFR 0.495 SOL -0.205 SOL -0.299 
ZAR/EUR -0.205 JSE Top 40 -0.396 SOL -0.044 JSE Top 40 0.171 JSE Top 40 -0.356 
JSE Top 
40 
-0.650 
JSE Top 40 -0.217 
JSE All 
Share 
-0.415 JSE Top 40 -0.110 SOL 0.082 
JSE All 
Share 
-0.359 
JSE All 
Share 
-0.662 
JSE All 
Share 
-0.225 ZAR/EUR -0.471 
JSE All 
Share 
-0.163 
JSE All 
Share 
0.008 ZAR/EUR -0.383 ZAR/EUR -0.881 
ZAR/USD -0.344 ZAR/USD -0.697 ZAR/USD -0.167 ZAR/USD -0.528 ZAR/USD -0.579 ZAR/USD -1.173 
CFR -0.628 CFR -0.912 
Kruger 
Rand 
-0.257 ZAR/EUR -0.545 ZAR/GBP -0.971 ZAR/GBP -1.374 
ZAR/GBP -0.818 ZAR/GBP -1.157 ZAR/EUR -0.332 Kruger Rand -0.754 CFR -1.566 CFR -2.272 
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(Table 5 continued) 
NORMAL SERIES (DAILY FREQUENCY) 
NORMAL SERIES (WEEKLY 
FREQUENCY) 
NORMAL SERIES (MONTHLY 
FREQUENCY) 
Traditional Sharpe SC adjusted Sharpe 
Traditional  
Sharpe ratio 
SC adjusted  
Sharpe ratio 
Traditional  
Sharpe ratio 
SC adjusted  
Sharpe ratio 
Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate Ranking Estimate 
Kruger 
Rand 
0.460 
Kruger 
Rand 
0.852 
Kruger 
Rand 
1.588 Kruger Rand 3.971 
Kruger 
Rand 
0.604 
Kruger 
Rand 
1.264 
JSE Top 40 -0.051 JSE Top 40 -0.071 SOL -0.242 SOL -0.354 SOL -0.166 ZAR/EUR -0.429 
SOL -0.059 ZAR/USD -0.182 
JSE All 
Share 
-0.453 
JSE All 
Share 
-0.917 
JSE All 
Share 
-0.202 
JSE Top 
40 
-0.438 
JSE All 
Share 
-0.093 SOL -0.186 JSE Top 40 -0.460 JSE Top 40 -1.284 
JSE Top 40 
-0.244 
JSE All 
Share 
-0.546 
ZAR/USD -0.128 
JSE All 
Share 
-0.286 ZAR/EUR -0.644 ZAR/EUR -1.707 
ZAR/EUR 
-0.273 
SOL 
-0.717 
ZAR/EUR -0.148 ZAR/EUR -0.427 ZAR/USD -0.800 CFR -2.319 ZAR/USD -0.341 ZAR/USD -0.754 
CFR -0.473 ZAR/GBP -0.899 CFR -0.917 ZAR/USD -2.519 CFR -0.574 CFR -1.568 
ZAR/GBP -0.643 CFR -1.419 ZAR/GBP -1.403 ZAR/GBP -3.222 ZAR/GBP -0.821 ZAR/GBP -1.680 
Source: Compiled by author. 
 
It also seems that the presence of correlation increased in the weekly and monthly data, as the serial 
correlated adjusted (SC) Sharpe ratio tended to differ more from the rankings provided by the traditional Sharpe 
ratio. Furthermore, it is interesting to note that rankings seemed to differ even between different data frequencies, 
which are true for the rankings based on both normally and non-normally distributed returns. This possibility is 
emphasised by the results reported in Table A in the Appendix, which illustrated that all data frequencies possess a 
certain level of non-normality and higher moments and increase as the data frequency increases. These results, 
therefore, confirm the argument that the level of normality and the presence of higher moments will lead to different 
Sharpe rankings, which can ultimately leads to misleading and unprofitable investment decisions. Financial analysts 
should also be wary about the data frequency used to evaluate their investment decisions, as it can also lead to 
different performance rankings. It is, therefore, recommended that financial analysts and fund managers must always 
standardise their data in terms of frequency and adjust for higher moments in order to eliminate all discrepancies 
that can occur when benchmarking a fund or portfolio’s performance.  
 
6. CONCLUSION AND RECOMMENDATIONS 
 
The general assumption is that daily and monthly return data are normally distributed, however, this paper 
has proven that this is not true for all markets. Evidence highlighted the fact that non-normal returns can be present 
in daily, weekly and monthly frequencies, although lower frequencies tended to exhibit less non-normal returns. 
This paper also illustrated that the return characteristics changed over the financial crisis period, where the presence 
of non-normality escalated in all data frequencies and remained higher during the post-financial crisis period 
compared to the pre-financial crisis period. This implies that financial analysts must still be wary about the adverse 
effect of non-normality and higher moments on risk-adjusted performance rankings, as it can lead to varying 
rankings. This argument was also proven, where the adjustment for higher moments and non-normality rendered 
different Sharpe rankings compared to rankings that are based on non-normal returns.  
 
Overall, the conclusion can be made that monthly data are more preferable, as it tends to be more normally 
distributed compared to daily or weekly returns. Precaution is, however, still advised as all investment returns do not 
necessarily share the same characteristics, as proven in this paper. Note also that this paper has provided evidence 
which suggest that the data frequency can also have a significant effect on the rankings of investments. It is, 
therefore, advised that fund managers must always standardise their data in terms of frequency and adjust for higher 
moments in order to eliminate possible discrepancies that can occur when benchmarking a fund’s performance. 
 
To conclude, although the standard deviation or VaR-model variations are generally used as denominator in 
the Sharpe ratio, future studies are still required to provide better substitutes. A possible alternative may be to 
incorporate the Kalman filter (Kalman, 1960) to include a level of “future risk”, which can overcome the general 
shortcoming of performance measures being backwards-looking. Furthermore, the greatest shortcoming of the 
Sharpe ratio is the use of a risk-free rate, which can differ depending on the investor’s risk-preference, thus leading 
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to different ranking possibilities. Future studies can focus on alternative approaches which can overcome this 
shortfall.  
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APPENDIX 
 
Table A: Summary Of Four Moments And Test For Normality 
  
ENTIRE SAMPLE (DAILY FREQUENCY) ENTIRE SAMPLE (WEEKLY FREQUENCY) 
Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW 
1-month 
JIBAR 
0.000 0.000 0.817 2.467 276.918* 15.977* 97.813* 0.179* 0.873* 0.001 0.000 0.805 2.427 57.494* 3.381* 20.721* 0.193* 0.847* 
3-month 
JIBAR 
0.000 0.000 0.802 2.490 265.834* 14.291* 90.135* 0.157* 0.879* 0.001 0.000 0.790 2.452 55.185* 3.029* 19.110* 0.169* 0.854* 
6-month 
JIBAR 
0.000 0.000 44.082 2040.178 390 x 109* 98.708* 507.111* 0.394* 0.078* 0.001 0.000 0.848 2.593 59.994* 2.950* 18.478* 0.172* 0.857* 
9-month 
JIBAR 
0.000 0.000 0.884 2.751 298.895* 12.819* 79.962* 0.129* 0.891* 0.001 0.000 0.874 2.717 61.734* 2.709* 16.878* 0.147* 0.865* 
12-month 
JIBAR 
0.000 0.000 0.890 2.820 300.152* 11.613* 73.249* 0.120* 0.898* 0.001 0.000 0.882 2.795 62.104* 2.441* 15.414* 0.133* 0.873* 
R157 0.000 0.000 -0.378 2.867 55.104* 6.827* 38.657* 0.102* 0.958* 0.001 0.000 -0.380 2.852 11.803* 1.437* 8.207* 0.101* 0.958* 
R186 0.000 0.000 0.293 3.022 32.320* 0.607* 5.695* 0.046* 0.985* 0.002 0.000 0.290 2.994 6.651* 0.156* 1.437* 0.041** 0.986* 
1-to-3 year 
bond index 
0.000 0.003 1.392 357.938 
11 811 
423.000* 
53.640* 291.679* 0.223* 0.309* 0.000 0.004 -2.708 76.739 
107 
741.000* 
4.679* 28.379* 0.152* 0.607* 
3-to-7 year 
bond index 
0.000 0.006 2.391 271.317 6 751 590.000* 48.401* 270.586* 0.209* 0.337* 0.000 0.008 1.642 40.040 27 251.840* 3.482* 21.951* 0.146* 0.714* 
12+ month 
bond index 
0.000 0.006 -0.167 4.928 358.862* 1.796* 10.524* 0.050* 0.980* 0.000 0.012 0.306 4.725 66.025* 0.291* 1.747* 0.046* 0.980* 
JSE All 
Share 
0.001 0.013 -0.101 6.523 1 167.566* 3.093* 19.082* 0.059* 0.957* 0.003 0.022 -0.225 5.028 85.072* 0.523* 3.149* 0.063* 0.978* 
JSE Top 40 0.001 0.014 -0.031 6.431 1 103.777* 2.975* 18.225* 0.057* 0.959* 0.003 0.024 -0.146 5.275 103.662* 0.525* 3.113* 0.065* 0.978* 
JSE Bank 0.001 0.017 0.142 5.388 542.197* 1.967* 12.247* 0.050* 0.974* 0.002 0.027 -0.123 4.536 47.685* 0.214* 1.462* 0.043** 0.983* 
JSE 
Financials 
0.000 0.013 0.062 6.097 900.358* 2.959* 18.078* 0.058* 0.963* 0.002 0.021 -0.414 5.005 92.724* 0.174* 1.300* 0.046* 0.984* 
JSE 
Industrials 
0.001 0.011 -0.119 5.500 591.090* 1.580* 10.158* 0.044* 0.975* 0.003 0.020 -0.479 3.700 27.705* 0.168* 1.152* 0.044* 0.985* 
AGL 0.001 0.025 0.161 7.431 1 850.071* 2.671* 17.508* 0.055* 0.952* 0.002 0.043 -0.241 5.300 108.802* 0.411* 2.776* 0.052* 0.977* 
BIL 0.001 0.023 0.507 8.311 2 740.582* 2.734* 17.317* 0.057* 0.950* 0.004 0.040 0.662 10.121 1 033.781* 0.272* 2.105* 0.035 0.981* 
CFR 0.001 0.021 -2.832 55.541 261 812.200* 3.917* 23.159* 0.063* 0.878* 0.004 0.035 -1.836 14.520 2 881.002* 0.635* 4.154* 0.044* 0.958* 
FSR 0.001 0.021 -0.066 4.980 369.105* 0.988* 5.863* 0.034* 0.984* 0.003 0.032 -0.367 4.841 77.388* 0.133* 1.211* 0.033 0.986* 
MTN 0.001 0.023 0.474 6.721 1 382.185* 1.798* 11.067* 0.049* 0.966* 0.004 0.033 0.223 4.201 32.334* 0.335* 1.889* 0.046* 0.987* 
NPN 0.001 0.021 0.022 4.129 119.756* 1.037* 5.597* 0.038* 0.991* 0.006 0.031 -0.158 3.257 3.269 0.057 0.361 0.034 0.995 
OML 0.001 0.023 -0.002 10.699 5 556.656* 6.337* 38.876* 0.088* 0.907* 0.002 0.036 -0.235 7.439 392.634* 0.910* 5.567* 0.072* 0.941* 
SAB 0.001 0.016 0.248 5.791 753.182* 1.300* 7.898* 0.047* 0.975* 0.004 0.025 0.004 4.111 24.337* 0.139* 0.993* 0.046* 0.990* 
SBK 0.000 0.019 0.230 5.643 674.558* 2.254* 13.436* 0.052* 0.972* 0.002 0.029 0.323 6.410 237.445* 0.292* 1.720* 0.049* 0.963* 
SOL 0.001 0.022 0.205 6.315 1 045.955* 2.519* 15.336* 0.055* 0.963* 0.004 0.036 -0.356 5.430 126.349* 0.260* 1.626* 0.048* 0.975* 
BGA 0.000 0.019 0.250 5.695 704.657* 2.831* 16.224* 0.064* 0.969* 0.002 0.030 -0.101 4.178 28.173* 0.273* 1.817* 0.055* 0.986* 
SLM 0.001 0.018 0.136 5.676 678.124* 2.313* 13.244* 0.050* 0.974* 0.003 0.026 -0.175 4.067 24.870* 0.254* 1.643* 0.046* 0.989* 
APN 0.001 0.020 0.157 5.289 500.389* 2.909* 16.345* 0.059* 0.971* 0.006 0.034 0.559 4.767 86.204* 0.328* 2.278* 0.053* 0.970* 
AMS 0.001 0.027 -0.151 5.526 606.907* 2.073* 12.509* 0.050* 0.973* 0.003 0.048 -0.210 5.000 82.285* 0.293* 1.859* 0.042** 0.983* 
ZAR/EUR 0.000 0.010 1.881 31.758 78 858.490* 4.698* 27.236* 0.074* 0.892* 0.001 0.017 0.698 5.420 153.891* 0.661* 4.112* 0.062* 0.969* 
ZAR/GBP 0.000 0.010 1.441 25.478 48 149.070* 3.256* 19.939* 0.060* 0.912* 0.001 0.017 0.255 5.107 87.938* 0.352* 2.388* 0.051* 0.979* 
ZAR/USD 0.000 0.012 1.689 26.778 54 073.270* 3.656* 21.451* 0.069* 0.908* 0.001 0.018 0.745 5.234 134.525* 0.177* 1.315* 0.038 0.972* 
Kruger 
Rand 
0.001 0.019 0.449 9.016 3 468.009* 43.327* 197.107* 0.265* 0.799* 0.004 0.022 0.477 4.930 91.343* 0.762* 3.996* 0.073* 0.970* 
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ENTIRE SAMPLE (MONTHLY FREQUENCY) PRE-FINANCIAL CRISIS PERIOD (DAILY FREQUENCY) 
Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW 
1-month 
JIBAR 
0.006 0.002 0.813 2.458 13.231* 0.763* 4.666* 0.176* 0.873* 0.000 0.000 1.423 3.888 184.755* 10.001* 54.939* 0.301* 0.730* 
3-month 
JIBAR 
0.006 0.002 0.799 2.484 12.703* 0.686* 4.318* 0.158* 0.879* 0.000 0.000 1.312 3.486 148.162* 7.975* 44.824* 0.244* 0.771* 
6-month 
JIBAR 
0.006 0.002 0.858 2.627 13.886* 0.670* 4.206* 0.157* 0.882* 0.000 0.001 22.230 495.796 
5 090 
305.000* 
38.045* 179.589* 0.482* 0.031* 
9-month 
JIBAR 
0.006 0.002 0.886 2.747 14.410* 0.623* 3.892* 0.150* 0.889* 0.000 0.000 1.135 2.713 108.932* 9.256* 50.034* 0.287* 0.765* 
12-month 
JIBAR 
0.006 0.002 0.893 2.819 14.486* 0.568* 3.587* 0.133* 0.896* 0.000 0.000 1.063 2.533 98.422* 8.719* 47.430* 0.259* 0.776* 
R157 0.006 0.001 -0.405 2.838 3.068 0.363* 2.054* 0.124* 0.954* 0.000 0.000 -0.015 2.173 14.233* 0.448* 3.782* 0.071* 0.971* 
R186 0.007 0.001 0.283 2.858 1.536 0.052 0.420 0.065 0.982 0.000 0.000 0.388 2.462 18.533* 0.645* 4.954* 0.070* 0.965* 
1-to-3 year 
bond index 
-0.002 0.006 0.223 6.354 51.523* 0.365* 2.276* 0.105* 0.927* 0.000 0.001 0.293 7.007 340.974* 1.207* 6.752* 0.089* 0.945* 
3-to-7 year 
bond index 
-0.001 0.013 0.181 7.260 82.262* 0.341* 2.228* 0.106* 0.916* 0.000 0.002 0.037 5.171 98.117* 0.568* 3.419* 0.061* 0.972* 
12+ month 
bond index 
-0.001 0.026 0.161 4.381 9.050* 0.136* 0.762* 0.073 0.979** 0.000 0.006 0.252 4.305 40.695* 0.363* 2.268* 0.051* 0.982* 
JSE All 
Share 
0.013 0.040 -1.516 7.142 118.564* 0.423* 2.310* 0.134* 0.900* 0.001 0.011 -0.446 7.159 376.219* 0.558* 3.875* 0.057* 0.950* 
JSE Top 40 0.013 0.042 -1.452 6.857 104.909* 0.387* 2.131* 0.132* 0.907* 0.001 0.012 -0.337 6.911 327.486* 0.509* 3.544* 0.052* 0.954* 
JSE Bank 0.010 0.046 -0.450 3.508 4.809** 0.062 0.431 0.049 0.983 0.001 0.017 0.118 5.276 108.880* 0.251* 1.633* 0.044* 0.979* 
JSE 
Financials 
0.009 0.040 -0.715 4.359 17.518* 0.160* 0.891* 0.087* 0.969* 0.001 0.012 -0.176 7.269 381.435* 0.565* 3.595* 0.060* 0.956* 
JSE 
Industrials 
0.012 0.043 -0.872 3.841 16.870* 0.250* 1.587* 0.104* 0.950* 0.001 0.012 -0.426 4.868 87.646* 0.228* 1.473* 0.049* 0.981* 
AGL 0.007 0.078 -0.477 4.290 11.575* 0.096 0.565 0.069 0.980 0.002 0.019 0.208 4.153 31.200* 0.101 0.751** 0.027 0.990* 
BIL 0.017 0.069 -0.269 3.799 4.178 0.073 0.431 0.063 0.987 0.002 0.019 -0.075 3.514 5.954** 0.082 0.516 0.034 0.996 
CFR 0.019 0.073 -2.259 14.306 667.043* 0.705* 3.980* 0.170* 0.815* 0.002 0.016 -0.290 7.971 520.658* 0.381* 2.524* 0.049* 0.955* 
FSR 0.010 0.056 -0.755 3.355 10.837* 0.159* 1.150* 0.081** 0.955* 0.001 0.020 -0.005 4.334 36.994* 0.117** 0.790* 0.039** 0.989* 
MTN 0.016 0.056 -0.232 3.199 1.142 0.039 0.246 0.045 0.993 0.002 0.023 0.206 3.834 18.014* 0.139* 0.753* 0.038** 0.992* 
NPN 0.027 0.062 -0.194 3.220 0.891 0.024 0.233 0.042 0.990 0.002 0.020 -0.003 3.865 15.575* 0.150* 0.892* 0.034 0.993* 
OML 0.009 0.075 0.134 5.628 31.404* 0.065 0.626 0.061 0.961* 0.001 0.016 -0.288 5.219 109.222* 0.249* 1.663* 0.054* 0.978* 
SAB 0.017 0.043 -0.647 4.133 13.322* 0.100 0.714** 0.076 0.969* 0.001 0.014 0.733 6.787 342.839* 0.128* 0.873* 0.032 0.969* 
SBK 0.007 0.046 -0.328 3.644 3.802 0.058 0.390 0.051 0.984 0.001 0.019 0.113 4.296 35.979* 0.227* 1.332* 0.040** 0.988* 
SOL 0.015 0.059 -0.796 5.401 37.343* 0.093 0.571 0.091* 0.963* 0.002 0.022 -0.159 4.642 58.182* 0.320* 1.970* 0.046* 0.981* 
BGA 0.007 0.054 0.040 3.225 0.257 0.065 0.394 0.071 0.990 0.001 0.018 0.454 6.598 286.252* 0.936* 4.952* 0.069* 0.958* 
SLM 0.014 0.048 -0.280 2.928 1.435 0.050 0.309 0.053 0.991 0.001 0.018 -0.184 4.299 37.908* 0.189* 1.046* 0.053* 0.989* 
APN 0.027 0.066 0.027 2.990 0.014 0.096 0.494 0.085** 0.990 0.001 0.019 0.190 4.514 50.658* 0.829* 4.403* 0.074* 0.975* 
AMS 0.010 0.092 -0.469 4.878 19.834* 0.136* 0.834* 0.104* 0.970* 0.003 0.026 0.065 4.182 29.411* 0.233* 1.489* 0.045* 0.987* 
ZAR/EUR 0.006 0.034 0.790 4.447 20.663* 0.180* 1.364* 0.078 0.953* 0.000 0.009 0.952 5.964 257.996* 0.778* 4.273* 0.084* 0.952* 
ZAR/GBP 0.005 0.036 0.792 4.726 24.683* 0.159* 1.008* 0.092* 0.960* 0.001 0.009 0.879 5.431 187.160* 0.554* 3.259* 0.070* 0.960* 
ZAR/USD 0.006 0.039 1.376 9.497 224.004* 0.131* 1.010* 0.070 0.916* 0.001 0.010 0.607 4.869 103.213* 0.665* 3.919* 0.081* 0.967* 
Kruger  
Rand 
0.016 0.048 0.900 5.662 46.477* 0.572* 3.155* 0.152* 0.916* 0.001 0.019 0.556 10.681 1 252.352* 10.527* 48.726* 0.260* 0.765* 
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PRE-FINANCIAL CRISIS PERIOD (WEEKLY FREQUENCY) PRE-FINANCIAL CRISIS PERIOD (MONTHLY FREQUENCY) 
Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW 
1-month 
JIBAR 
0.001 0.000 1.461 3.990 41.242* 2.123* 11.582* 0.316* 0.681* 0.006 0.000 1.466 4.002 9.604* 0.471* 2.563* 0.271* 0.737* 
3-month 
JIBAR 
0.001 0.000 1.348 3.567 32.877* 1.727* 9.612* 0.236* 0.737* 0.006 0.000 1.364 3.601 7.809* 0.394* 2.188* 0.225* 0.772* 
6-month 
JIBAR 
0.001 0.000 1.244 3.113 26.864* 1.741* 9.432* 0.240* 0.747* 0.006 0.001 1.244 3.119 6.201* 0.400* 2.166* 0.273* 0.783* 
9-month 
JIBAR 
0.001 0.000 1.156 2.752 23.425* 1.990* 10.691* 0.281* 0.717* 0.006 0.001 1.187 2.808 5.674** 0.482* 2.573* 0.319* 0.753* 
12-month 
JIBAR 
0.001 0.000 1.082 2.572 21.077* 1.854* 10.047* 0.248* 0.736* 0.006 0.001 1.114 2.629 5.097** 0.454* 2.440* 0.295* 0.764* 
R157 0.002 0.000 -0.037 2.113 3.434 0.110** 0.965* 0.094** 0.965* 0.007 0.000 -0.140 2.116 0.860 0.039 0.293 0.097 0.961 
R186 0.001 0.000 0.391 2.441 4.003 0.150* 1.169* 0.076 0.962* 0.006 0.000 0.380 2.486 0.843 0.045 0.321 0.118 0.960 
1-to-3 year 
bond index 
-0.001 0.002 0.576 6.475 58.091* 0.174* 1.115* 0.094** 0.956* -0.003 0.004 -0.535 3.009 1.144 0.051 0.341 0.113 0.961 
3-to-7 year 
bond index 
-0.001 0.004 0.035 4.488 9.620* 0.098 0.595 0.061 0.985 -0.003 0.009 -0.536 3.186 1.184 0.039 0.295 0.113 0.959 
12+ month 
bond index 
0.000 0.010 0.076 3.162 0.215 0.080 0.483 0.073 0.985 0.001 0.024 -0.187 2.565 0.330 0.020 0.128 0.082 0.988 
JSE All 
Share 
0.007 0.020 -0.506 4.440 13.428* 0.261* 1.492* 0.096** 0.970* 0.029 0.028 -0.990 3.888 4.708** 0.072 0.557 0.152 0.918** 
JSE Top 40 0.007 0.021 -0.390 4.438 11.604* 0.238* 1.369* 0.089** 0.969* 0.029 0.028 -0.757 3.382 2.437 0.052 0.428 0.117 0.939 
JSE Bank 0.005 0.027 0.085 2.774 0.348 0.093 0.474 0.093** 0.987 0.019 0.041 -0.409 2.497 0.922 0.034 0.226 0.102 0.973 
JSE 
Financials 
0.005 0.019 -0.144 2.650 0.890 0.066 0.413 0.072 0.984 0.022 0.033 -0.645 2.692 1.759 0.068 0.468 0.111 0.946 
JSE 
Industrials 
0.006 0.021 -0.501 3.260 4.639** 0.077 0.471 0.087 0.978 0.025 0.042 -0.767 3.037 2.356 0.063 0.444 0.117 0.943 
AGL 0.010 0.034 0.146 4.503 10.161* 0.042 0.396 0.055 0.971** 0.041 0.044 0.304 2.230 0.963 0.046 0.308 0.116 0.961 
BIL 0.007 0.030 -0.228 3.413 1.640 0.062 0.442 0.065 0.990 0.031 0.058 0.410 2.450 0.974 0.069 0.438 0.134 0.949 
CFR 0.008 0.025 -0.318 3.277 2.087 0.030 0.223 0.072 0.987 0.033 0.039 1.585 5.451 16.055* 0.168* 1.118* 0.179* 0.847* 
FSR 0.005 0.032 0.181 2.814 0.721 0.086 0.524 0.058 0.988 0.019 0.045 -0.387 2.535 0.816 0.037 0.250 0.101 0.970 
MTN 0.007 0.036 0.114 3.454 1.118 0.054 0.346 0.056 0.989 0.029 0.058 0.206 3.216 0.217 0.034 0.224 0.093 0.982 
NPN 0.008 0.032 0.072 2.890 0.141 0.034 0.198 0.078 0.991 0.033 0.057 -0.086 1.828 1.403 0.052 0.345 0.128 0.955 
OML 0.005 0.026 0.137 3.993 4.601 0.112** 0.621 0.078 0.979 0.021 0.041 -0.024 1.915 1.179 0.049 0.338 0.110 0.959 
SAB 0.005 0.023 0.705 4.321 16.191* 0.106** 0.736** 0.078 0.962* 0.021 0.030 -0.371 2.517 0.784 0.030 0.248 0.087 0.966 
SBK 0.004 0.028 0.116 2.623 0.851 0.069 0.411 0.065 0.987 0.016 0.039 -0.094 2.625 0.176 0.025 0.181 0.089 0.982 
SOL 0.008 0.039 -0.332 3.153 2.011 0.031 0.212 0.041 0.992 0.035 0.054 -0.007 1.991 1.018 0.037 0.259 0.092 0.966 
BGA 0.005 0.030 -0.123 3.292 0.631 0.056 0.332 0.069 0.988 0.021 0.052 -0.165 2.828 0.139 0.049 0.254 0.139 0.980 
SLM 0.004 0.027 -0.060 3.134 0.140 0.049 0.339 0.047 0.990 0.016 0.050 -0.016 2.314 0.472 0.018 0.169 0.081 0.975 
APN 0.006 0.036 0.643 4.033 11.795* 0.091 0.652** 0.071 0.973** 0.028 0.072 -0.031 2.122 0.774 0.060 0.352 0.138 0.961 
AMS 0.015 0.049 0.507 5.511 31.763* 0.091 0.572 0.090** 0.945* 0.062 0.055 1.008 4.144 5.373** 0.056 0.422 0.121 0.928** 
ZAR/EUR 0.002 0.015 0.850 4.314 20.000* 0.140* 0.990* 0.110* 0.963* 0.009 0.033 1.146 3.844 5.967** 0.139* 0.929* 0.175** 0.888* 
ZAR/GBP 0.002 0.014 0.290 3.069 1.296 0.065 0.446 0.084 0.983 0.010 0.036 0.994 3.932 4.824** 0.117** 0.691** 0.183* 0.917** 
ZAR/USD 0.002 0.017 0.408 2.800 2.740 0.041 0.381 0.055 0.982 0.009 0.038 0.321 2.487 0.676 0.028 0.232 0.097 0.967 
Kruger 
Rand 
0.006 0.018 0.680 3.590 9.519* 0.319* 1.715* 0.128* 0.946* 0.026 0.035 1.898 7.138 31.536* 0.235* 1.343* 0.201* 0.817* 
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DURING FINANCIAL CRISIS PERIOD (DAILY FREQUENCY) DURING FINANCIAL CRISIS PERIOD (WEEKLY FREQUENCY) 
Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW 
1-month 
JIBAR 
0.000 0.000 -0.387 1.903 56.383* 2.443* 19.645* 0.127* 0.908* 0.002 0.000 -0.408 1.916 12.201* 0.546* 4.280* 0.135* 0.906* 
3-month 
JIBAR 
0.000 0.000 -0.291 1.807 55.135* 2.235* 17.669* 0.122* 0.918* 0.002 0.000 -0.311 1.811 11.922* 0.501* 3.851* 0.130* 0.916* 
6-month 
JIBAR 
0.000 0.000 -0.116 1.727 52.347* 1.851* 14.217* 0.104* 0.933* 0.002 0.000 -0.133 1.729 11.170* 0.403* 3.044* 0.103* 0.932* 
9-month 
JIBAR 
0.000 0.000 0.044 1.739 49.991* 1.769* 13.510* 0.119* 0.938* 0.002 0.000 0.035 1.737 10.596* 0.376* 2.883* 0.123* 0.937* 
12-month 
JIBAR 
0.000 0.000 0.145 1.760 50.780* 2.110* 14.827* 0.122* 0.936* 0.002 0.000 0.146 1.757 10.806* 0.464* 3.238* 0.128* 0.934* 
R157 0.000 0.000 0.993 4.148 164.600* 2.159* 12.738* 0.118* 0.936* 0.002 0.000 0.960 4.099 32.418* 0.444* 2.597* 0.123* 0.938* 
R186 0.000 0.000 0.265 2.987 8.808* 0.521* 4.477* 0.052* 0.974* 0.002 0.000 0.253 2.944 1.713 0.122** 1.078* 0.067** 0.970* 
1-to-3 year 
bond index 
0.000 0.005 0.967 152.622 700 633.200* 27.406* 144.657* 0.287* 0.254* 0.000 0.006 -2.259 41.726 10 070.850* 2.418* 13.550* 0.191* 0.594* 
3-to-7 year 
bond index 
0.000 0.010 1.655 113.744 384 112.700* 24.143* 135.448* 0.270* 0.303* 0.000 0.011 1.573 23.420 2 827.914* 1.936* 10.735* 0.197* 0.710* 
12+ month 
bond index 
0.000 0.007 -0.253 5.625 223.646* 1.109* 6.459* 0.068* 0.965* -0.001 0.014 0.678 5.162 43.131* 0.181* 1.211* 0.074* 0.964* 
JSE All 
Share 
0.000 0.017 0.024 4.947 118.749* 0.610* 3.814* 0.054* 0.977* 0.001 0.030 -0.015 3.898 5.345** 0.088 0.572 0.056 0.986 
JSE Top 40 0.000 0.019 0.080 4.946 119.311* 0.600* 3.772* 0.059* 0.977* 0.001 0.032 0.056 4.144 8.760* 0.085 0.578 0.054 0.983** 
JSE Bank 0.000 0.022 0.189 4.195 49.161* 0.570* 3.272* 0.059* 0.985* 0.001 0.036 -0.123 3.743 4.057 0.121** 0.843* 0.067** 0.980* 
JSE 
Financials 
0.000 0.017 0.210 4.442 70.585* 0.514* 3.240* 0.050* 0.983* -0.001 0.028 -0.296 3.919 7.925* 0.068 0.503 0.057 0.986 
JSE 
Industrials 
0.000 0.014 0.032 4.914 114.788* 0.491* 3.120* 0.043* 0.980* 0.000 0.025 -0.479 3.140 6.204* 0.105** 0.646** 0.063 0.984** 
AGL 0.000 0.035 0.121 5.496 196.761* 0.874* 5.314* 0.066* 0.968* 0.001 0.058 -0.218 4.055 8.627* 0.157* 1.027* 0.073* 0.978* 
BIL 0.001 0.032 0.543 6.438 406.680* 1.070* 6.102* 0.067* 0.960* 0.005 0.055 0.775 7.972 179.675* 0.116** 1.068* 0.065** 0.940* 
CFR 0.000 0.026 -4.277 65.321 123 822.200* 2.100* 12.559* 0.083* 0.800* -0.002 0.046 -2.153 12.885 770.244* 0.594* 3.580* 0.111* 0.855* 
FSR 0.000 0.026 0.025 4.056 34.965* 0.244* 1.409* 0.037* 0.992* 0.000 0.040 -0.397 4.393 17.016* 0.107** 0.810* 0.054 0.977* 
MTN 0.001 0.029 0.619 6.093 347.337* 0.920* 5.601* 0.065* 0.962* 0.003 0.040 0.293 3.595 4.614** 0.134* 0.711** 0.073* 0.988 
NPN 0.001 0.024 0.079 3.736 17.720* 0.172* 0.927* 0.033** 0.995* 0.004 0.037 -0.296 2.944 2.346 0.070 0.441 0.055 0.990 
OML 0.000 0.032 0.174 6.412 368.136* 1.625* 9.534* 0.081* 0.950* -0.003 0.049 0.027 5.153 30.722* 0.270* 1.552* 0.093* 0.966* 
SAB 0.001 0.020 0.288 4.860 118.592* 0.330* 2.182* 0.044* 0.982* 0.002 0.031 -0.135 3.245 0.883 0.031 0.206 0.043 0.995 
SBK 0.000 0.025 0.319 4.676 100.673* 0.783* 4.220* 0.066* 0.979* 0.001 0.038 0.393 5.610 49.224* 0.105** 0.745** 0.064 0.969* 
SOL 0.001 0.028 0.329 5.169 160.762* 0.709* 4.386* 0.065* 0.971* 0.002 0.046 -0.345 4.666 21.544* 0.104** 0.646** 0.060 0.979* 
BGA 0.000 0.024 0.270 4.369 67.824* 0.548* 3.037* 0.049* 0.985* 0.001 0.038 -0.133 3.311 1.108 0.073 0.542 0.053 0.986 
SLM 0.001 0.022 0.314 5.209 165.070* 0.584* 3.475* 0.048* 0.978* 0.002 0.031 -0.168 3.671 3.723 0.086 0.510 0.054 0.988 
APN 0.001 0.025 0.081 4.544 75.397* 0.638* 3.797* 0.053* 0.980* 0.006 0.039 0.334 4.189 12.321* 0.057 0.481 0.044 0.983** 
AMS 0.001 0.035 -0.317 4.583 90.986* 0.583* 3.495* 0.048* 0.981* 0.001 0.062 -0.543 3.551 9.830* 0.107** 0.703** 0.053 0.982* 
ZAR/EUR 0.000 0.013 2.187 30.345 23 997.660* 1.971* 12.175* 0.091* 0.860* 0.001 0.019 0.399 4.925 28.780* 0.255* 1.477* 0.080* 0.967* 
ZAR/GBP 0.000 0.014 1.773 25.297 15 950.890* 1.379* 9.562* 0.076* 0.883* -0.001 0.021 0.226 4.816 23.204* 0.236* 1.402* 0.074* 0.969* 
ZAR/USD 0.000 0.015 2.111 26.625 18 022.980* 1.410* 9.410* 0.072* 0.875* 0.001 0.023 1.261 6.865 141.129* 0.290* 1.793* 0.087* 0.930* 
Kruger  
Rand 
0.001 0.021 0.234 7.165 549.797* 12.560* 57.363* 0.259* 0.833* 0.004 0.026 0.684 5.108 41.826* 0.368* 1.982* 0.094* 0.956* 
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DURING FINANCIAL CRISIS PERIOD (MONTHLY FREQUENCY) POST-FINANCIAL CRISIS PERIOD (DAILY FREQUENCY) 
Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW 
1-month 
JIBAR 
0.008 0.001 -0.392 1.910 2.703 0.117** 0.927* 0.142** 0.909* 0.000 0.000 1.173 3.512 240.318* 11.982* 67.810* 0.292* 0.819* 
3-month 
JIBAR 
0.008 0.001 -0.292 1.802 2.663 0.111** 0.869* 0.142** 0.916* 0.000 0.000 1.269 3.743 291.413* 13.927* 76.998* 0.300* 0.796* 
6-month 
JIBAR 
0.008 0.001 -0.115 1.710 2.576 0.095 0.729** 0.111 0.929* 0.000 0.000 1.486 4.649 481.425* 11.472* 62.850* 0.272* 0.817* 
9-month 
JIBAR 
0.008 0.001 0.046 1.708 2.516 0.093 0.715** 0.129 0.931* 0.000 0.000 1.394 4.489 416.066* 9.140* 51.632* 0.224* 0.844* 
12-month 
JIBAR 
0.008 0.001 0.148 1.728 2.558 0.110** 0.792* 0.139** 0.928* 0.000 0.000 1.281 4.171 330.452* 7.354* 43.890* 0.186* 0.862* 
R157 0.007 0.001 1.000 3.823 7.014* 0.144* 0.880* 0.173* 0.916* 0.000 0.000 0.035 1.847 55.615* 1.595* 12.185* 0.089* 0.956* 
R186 0.007 0.001 0.237 2.732 0.445 0.048 0.379 0.101 0.963 0.000 0.000 -0.414 2.597 35.263* 1.120* 6.779* 0.061* 0.977* 
1-to-3 year 
bond index 
-0.002 0.008 0.536 4.039 3.340 0.133* 0.735** 0.154* 0.953 0.000 0.001 -0.393 8.061 1 093.181* 2.244* 13.021* 0.082* 0.938* 
3-to-7 year 
bond index 
-0.001 0.018 1.044 4.261 8.932* 0.256* 1.456* 0.191* 0.899* 0.000 0.003 -0.632 6.547 590.792* 1.221* 7.231* 0.065* 0.961* 
12+ month 
bond index 
-0.004 0.031 0.768 4.133 5.464** 0.128* 0.719** 0.154* 0.946** 0.000 0.006 -0.230 4.241 73.055* 0.500* 2.933* 0.052* 0.987* 
JSE All 
Share 
0.005 0.056 -1.228 4.695 13.363* 0.151* 0.905* 0.161* 0.903* 0.001 0.010 -0.155 4.281 72.349* 0.561* 3.478* 0.049* 0.986* 
JSE Top 40 0.005 0.058 -1.179 4.526 11.830* 0.137* 0.832* 0.146** 0.910* 0.001 0.011 -0.104 4.214 63.166* 0.564* 3.450* 0.051* 0.986* 
JSE Bank 0.003 0.062 -0.300 2.632 0.744 0.053 0.380 0.094 0.967 0.001 0.013 -0.027 4.203 60.393* 0.210* 1.515* 0.026 0.991* 
JSE 
Financials 
-0.002 0.054 -0.261 2.982 0.408 0.031 0.188 0.081 0.988 0.001 0.009 -0.133 4.877 149.709* 0.546* 3.458* 0.049* 0.982* 
JSE 
Industrials 
0.002 0.054 -0.662 2.840 2.670 0.118** 0.676** 0.122 0.950 0.001 0.009 -0.093 4.193 60.760* 0.338* 2.332* 0.040* 0.988* 
AGL 0.002 0.106 -0.444 3.172 1.225 0.065 0.340 0.120 0.979 0.000 0.019 0.242 3.673 28.686* 0.114** 0.820* 0.029* 0.994* 
BIL 0.020 0.090 -0.372 3.000 0.832 0.044 0.304 0.088 0.977 0.000 0.017 0.191 3.661 24.330* 0.130* 1.025* 0.029** 0.994* 
CFR -0.007 0.100 -2.163 9.219 86.081* 0.431* 2.461* 0.218* 0.780* 0.002 0.018 0.092 4.814 138.573* 0.817* 4.690* 0.051* 0.980* 
FSR -0.001 0.073 -0.504 2.330 2.199 0.081 0.540 0.122 0.948** 0.001 0.016 -0.291 5.015 183.258* 0.174* 0.978* 0.031* 0.987* 
MTN 0.013 0.070 -0.393 2.353 1.554 0.050 0.335 0.088 0.969 0.001 0.017 -0.017 3.902 33.947* 0.142 0.744** 0.028** 0.994* 
NPN 0.021 0.076 -0.416 2.841 1.074 0.030 0.261 0.071 0.970 0.001 0.018 -0.044 4.043 45.623* 0.592* 3.297* 0.052* 0.989* 
OML -0.010 0.106 0.578 4.281 4.468 0.061 0.381 0.109 0.963 0.001 0.016 -0.606 16.417 7 561.785* 0.909* 5.791* 0.060* 0.923* 
SAB 0.012 0.058 -0.589 3.059 2.086 0.091 0.546 0.111 0.959 0.001 0.013 -0.131 4.502 96.875* 0.447* 2.445* 0.041* 0.988* 
SBK 0.005 0.061 -0.341 2.779 0.773 0.055 0.389 0.086 0.967 0.000 0.014 -0.118 4.171 59.457* 0.194* 1.543* 0.032* 0.990* 
SOL 0.007 0.076 -0.816 4.484 7.298* 0.067 0.422 0.122 0.954 0.001 0.015 0.029 3.538 12.217* 0.156* 0.939* 0.027** 0.996* 
BGA 0.004 0.069 0.108 2.683 0.221 0.037 0.238 0.076 0.981 0.000 0.015 -0.049 5.147 192.509* 0.637* 3.784* 0.054* 0.980* 
SLM 0.008 0.059 -0.162 2.469 0.580 0.022 0.151 0.066 0.987 0.001 0.014 -0.012 4.559 101.236* 1.007* 5.670* 0.052* 0.980* 
APN 0.025 0.075 -0.111 3.159 0.112 0.069 0.359 0.119 0.981 0.001 0.016 0.306 4.683 133.596* 0.747* 4.440* 0.051* 0.981* 
AMS 0.006 0.122 -0.924 3.554 5.584** 0.204* 1.068* 0.167* 0.927* 0.000 0.020 0.274 4.015 55.418* 0.395* 2.229* 0.043* 0.990* 
ZAR/EUR 0.005 0.042 0.843 4.432 7.344* 0.125* 0.892* 0.122 0.929* 0.000 0.008 0.476 4.810 174.278* 0.657* 4.331* 0.047* 0.978* 
ZAR/GBP -0.003 0.042 1.230 5.509 18.520* 0.125** 0.804** 0.137** 0.912* 0.000 0.008 0.247 4.135 63.908* 0.565* 3.284* 0.046* 0.987* 
ZAR/USD 0.003 0.052 1.824 9.498 83.290* 0.199* 1.268* 0.150* 0.849* 0.000 0.009 0.287 4.505 108.170* 0.592* 3.487* 0.047* 0.984* 
Kruger  
Rand 
0.019 0.062 0.759 4.373 6.284* 0.240* 1.266* 0.174* 0.922* 0.001 0.017 0.640 10.016 2 119.359* 20.308* 91.525* 0.275* 0.788* 
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POST-FINANCIAL CRISIS PERIOD (WEEKLY FREQUENCY) POST-FINANCIAL CRISIS PERIOD (MONTHLY FREQUENCY) 
Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW Mean Std. Dev. Skew. Kurt. JB CVM AD KS SW 
1-month 
JIBAR 
0.001 0.000 1.190 3.557 52.262* 2.516* 14.289* 0.290* 0.817* 0.004 0.000 1.180 3.502 11.643* 0.567* 3.198* 0.285* 0.822* 
3-month 
JIBAR 
0.001 0.000 1.286 3.788 63.269* 2.912* 16.128* 0.301* 0.796* 0.005 0.000 1.278 3.739 14.159* 0.655* 3.613* 0.298* 0.801* 
6-month 
JIBAR 
0.001 0.000 1.498 4.697 103.766* 2.428* 13.278* 0.276* 0.816* 0.005 0.000 1.491 4.600 22.914* 0.586* 3.167* 0.295* 0.815* 
9-month 
JIBAR 
0.001 0.000 1.402 4.523 89.140* 1.928* 10.898* 0.225* 0.842* 0.005 0.001 1.408 4.463 20.136* 0.465* 2.608* 0.225* 0.841* 
12-month 
JIBAR 
0.001 0.000 1.286 4.195 70.378* 1.548* 9.256* 0.186* 0.860* 0.005 0.001 1.299 4.162 16.204* 0.395* 2.312* 0.209* 0.855* 
R157 0.001 0.000 0.038 1.832 11.986* 0.356* 2.734* 0.094* 0.953* 0.006 0.001 0.035 1.845 2.680 0.091 0.668** 0.096 0.951* 
R186 0.002 0.000 -0.422 2.574 7.819* 0.282* 1.737* 0.077* 0.973* 0.007 0.000 -0.400 2.548 1.688 0.095 0.549 0.121** 0.968 
1-to-3 year 
bond index 
0.000 0.002 -0.596 5.329 59.926* 0.264* 1.674* 0.074* 0.963* -0.002 0.005 -0.973 9.078 81.440* 0.140* 1.125* 0.114 0.879* 
3-to-7 year 
bond index 
0.000 0.005 -0.977 5.625 93.733* 0.386* 2.338* 0.101* 0.949* 0.000 0.011 -2.398 14.013 288.586* 0.280* 1.796* 0.155* 0.798* 
12+ month 
bond index 
0.000 0.010 -0.121 3.634 4.030 0.169* 0.923* 0.061** 0.989** 0.001 0.024 -0.471 5.690 16.249* 0.083 0.618 0.087 0.942* 
JSE All 
Share 
0.003 0.016 -0.372 3.264 5.465** 0.111** 0.752* 0.056 0.985* 0.011 0.028 -0.773 3.521 5.323** 0.110** 0.648** 0.108 0.954** 
JSE Top 40 0.003 0.017 -0.369 3.270 5.403** 0.128* 0.810* 0.060** 0.985* 0.010 0.030 -0.735 3.462 4.748** 0.106** 0.626** 0.108 0.958** 
JSE Bank 0.002 0.019 -0.050 2.581 1.624 0.043 0.287 0.035 0.993 0.010 0.033 -0.135 2.179 1.493 0.048 0.330 0.085 0.978 
JSE 
Financials 
0.003 0.014 -0.102 2.650 1.435 0.024 0.225 0.028 0.992 0.012 0.027 -0.531 3.316 2.459 0.065 0.403 0.095 0.975 
JSE 
Industrials 
0.003 0.016 -0.041 2.856 0.241 0.025 0.209 0.035 0.996 0.012 0.031 -0.728 3.164 4.291 0.076 0.627** 0.091 0.947* 
AGL -0.001 0.033 -0.283 3.162 3.038 0.082 0.548 0.049 0.990 -0.006 0.061 0.125 3.078 0.138 0.020 0.145 0.058 0.992 
BIL 0.002 0.029 -0.139 2.954 0.694 0.042 0.263 0.038 0.995 0.007 0.053 -0.583 3.469 3.158 0.074 0.455 0.097 0.967 
CFR 0.007 0.029 -0.059 2.941 0.152 0.059 0.385 0.039 0.994 0.032 0.056 0.034 3.519 0.548 0.061 0.327 0.120** 0.987 
FSR 0.003 0.025 -0.372 3.466 6.748* 0.031 0.310 0.030 0.987* 0.014 0.046 -0.632 3.328 3.409 0.080 0.613 0.095 0.950* 
MTN 0.003 0.024 0.013 3.712 4.439 0.115** 0.663** 0.053 0.990 0.012 0.040 -0.256 2.237 1.689 0.073 0.495 0.100 0.965 
NPN 0.007 0.027 0.026 3.206 0.396 0.052 0.330 0.042 0.995 0.028 0.054 0.430 3.348 1.719 0.030 0.210 0.078 0.982 
OML 0.004 0.027 -0.509 8.450 268.947* 0.099 0.782* 0.044 0.946* 0.017 0.056 -0.046 2.333 0.907 0.027 0.184 0.066 0.984 
SAB 0.004 0.019 0.078 3.364 1.374 0.039 0.288 0.039 0.995 0.019 0.034 0.054 2.110 1.607 0.048 0.379 0.087 0.969 
SBK 0.001 0.020 0.063 3.209 0.521 0.019 0.122 0.029 0.998 0.005 0.033 0.011 2.309 0.956 0.034 0.277 0.069 0.979 
SOL 0.003 0.024 -0.164 3.001 0.945 0.050 0.306 0.044 0.996 0.012 0.042 -0.722 3.010 4.173 0.139* 0.787* 0.121** 0.952* 
BGA 0.000 0.022 0.037 4.531 20.558* 0.049 0.459 0.042 0.984* 0.001 0.041 -0.079 2.940 0.057 0.031 0.232 0.071 0.987 
SLM 0.004 0.020 -0.100 3.991 8.937* 0.076 0.610 0.051 0.988** 0.018 0.036 -0.350 2.473 1.534 0.087 0.509 0.104 0.968 
APN 0.007 0.028 0.879 5.589 85.701* 0.280* 1.823* 0.080* 0.953* 0.029 0.057 0.380 2.854 1.201 0.071 0.469 0.100 0.971 
AMS -0.003 0.034 -0.050 3.629 3.543 0.064 0.437 0.045 0.991 -0.013 0.071 1.378 7.529 56.218* 0.168* 1.031* 0.136* 0.902* 
ZAR/EUR 0.002 0.015 1.079 5.847 111.639* 0.329* 1.982* 0.076* 0.946* 0.006 0.030 0.405 3.171 1.370 0.023 0.179 0.058 0.986 
ZAR/GBP 0.002 0.015 0.544 4.738 36.782* 0.172* 1.083* 0.052 0.975* 0.007 0.030 0.151 3.364 0.447 0.022 0.153 0.059 0.993 
ZAR/USD 0.002 0.017 0.741 5.078 57.004* 0.071 0.593 0.045 0.969* 0.007 0.028 0.278 2.513 1.094 0.035 0.224 0.079 0.983 
Kruger  
Rand 
0.002 0.021 0.110 3.579 3.354 0.146* 0.822* 0.057** 0.989 0.010 0.040 0.700 4.593 8.998* 0.152* 0.933* 0.136* 0.945* 
Source: Compiled by author. 
Note: Std. Dev denotes standard deviation; Skew. denotes skewness; Kurt. denotes kurtosis; JB denotes Jarque-Bera; CVM denotes Cramer-von Mises; AD denotes Anderson-Darling; KS denotes 
Kolmogorov-Smirnov; SW denotes Shapiro-Wilk. 
Note: * illustrate that the null hypothesis for normality is rejected at the 5% level of significance; ** illustrate that the null hypothesis for normality is rejected at the 10% level of significance 
 
